Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04135950 · ClinicalTrials.gov registry record

Prospective Registry of Anterior Cruciate Ligament Reconstructions

A clinical trial of Anterior Cruciate Ligament Tear and Cartilage Injury, sponsored by State University of New York at Buffalo.

Completed
Registry status
1,646
Enrollment target
1
Study location

NCT04135950 is a study of Anterior Cruciate Ligament Tear and Cartilage Injury that has completed, run by State University of New York at Buffalo. The registered enrollment target is 1,646 participants, above the 81-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (1932% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04135950, a study of Anterior Cruciate Ligament Tear and Cartilage Injury, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
1,646 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to investigate factors that are associated with outcomes of injury to the anterior cruciate ligament (ACL) in the knee among patients who are undergoing surgical reconstruction. This study is a registry of all patients having knee surgery at our institution performed by 4 fellowship-trained orthopaedic surgeons. The surgeon documents patient information on standard data forms including risk factors and surgical findings.

Study Locations (1)

New York

  • UBMD Orthopaedics and Sports Medicine - Buffalo

Trial Details

FieldValue
Enrollment Target 1,646 participants
Start Date 2005-01
Est. Completion 2025-10-28

What the Registry Record Tells You About NCT04135950

The ClinicalTrials.gov registry entry for NCT04135950 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,646 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 81-participant average among 11 other Anterior Cruciate Ligament Tear trials with a reported enrollment target (1932% higher). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Anterior Cruciate Ligament Tear appearing as the primary indexed condition, and to 0 interventions.

NCT04135950 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04135950 about?

NCT04135950 is a clinical study titled "Prospective Registry of Anterior Cruciate Ligament Reconstructions". The purpose of the study is to investigate factors that are associated with outcomes of injury to the anterior cruciate ligament (ACL) in the knee among patients who are undergoing surgical reconstruction. This study is a registry of all patients having knee surgery at our institution performed by 4...

What is the current status of trial NCT04135950?

This trial is currently completed. The enrollment target is 1,646 participants. The study started on 2005-01. Estimated completion is 2025-10-28.

What conditions does trial NCT04135950 study?

This clinical trial studies the following conditions: Anterior Cruciate Ligament Tear, Cartilage Injury, Meniscal Tear, Bone Bruising.

Who is sponsoring clinical trial NCT04135950?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04135950 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anterior Cruciate Ligament Tear

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.